Reposted by Cincinnati Children's
A Cincinnati Children's led study, recently published in The Lancet Haematology, found that long-term data from the REACH trial show hydroxyurea safely treats children with #sicklecell anemia in Africa without increasing the risk of serious infections, expanding access to care.
scienceblog.cincinnatichildrens.org
Children Living With Sickle Cell Can Be Treated Safely Using Hydroxyurea - Research Horizons
Long-term REACH trial data show hydroxyurea safely treats children with sickle cell anemia in Africa without increasing serious infections.